| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ashraf Mahmud, Petio Petrov, Guillem R Esber, Mihaela D Iordanov. The serial blocking effect: a testbed for the neural mechanisms of temporal-difference learning. Scientific reports. vol 9. issue 1. 2020-10-16. PMID:30979910. |
the application of these models to understanding the role of phasic midbrain dopaminergic responses in reward prediction learning constitutes one of the greatest success stories in behavioural and cognitive neuroscience. |
2020-10-16 |
2023-08-13 |
Not clear |
| Carles Calatayud, Giulia Carola, Irene Fernández-Carasa, Marco Valtorta, Senda Jiménez-Delgado, Mònica Díaz, Jordi Soriano-Fradera, Graziella Cappelletti, Javier García-Sancho, Ángel Raya, Antonella Consigli. CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons. Scientific reports. vol 9. issue 1. 2020-10-16. PMID:31048719. |
we also employed calcium imaging techniques to determine the intrinsic functional differences between dopaminergic and non-dopaminergic ventral midbrain neurons. |
2020-10-16 |
2023-08-13 |
human |
| Anupam Raina, Sameehan Mahajani, Mathias Bähr, Sebastian Kügle. Neuronal Trans-differentiation by Transcription Factors Ascl1 and Nurr1: Induction of a Dopaminergic Neurotransmitter Phenotype in Cortical GABAergic Neurons. Molecular neurobiology. vol 57. issue 1. 2020-10-07. PMID:31317490. |
intriguingly, gabaergic neurons isolated from embryonal midbrain could not be trans-differentiated into dopaminergic neurons by ascl1 and nurr1. |
2020-10-07 |
2023-08-13 |
rat |
| Liting Hang, John Thundyil, Geraldine W Y Goh, Kah-Leong Li. AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression. Neuromolecular medicine. vol 21. issue 1. 2020-10-02. PMID:30411223. |
parkinson's disease (pd) is a prevalent neurodegenerative movement disorder that is characterized pathologically by the progressive loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc) of the midbrain. |
2020-10-02 |
2023-08-13 |
mouse |
| Mary Gazea, Evangelia Tasouri, Tobias Heigl, Viktoria Bosch, Kerry L Tucker, Sandra Blaes. Definition of a critical spatiotemporal window within which primary cilia control midbrain dopaminergic neurogenesis. Neurogenesis (Austin, Tex.). vol 3. issue 1. 2020-10-01. PMID:28090543. |
definition of a critical spatiotemporal window within which primary cilia control midbrain dopaminergic neurogenesis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Mary Gazea, Evangelia Tasouri, Tobias Heigl, Viktoria Bosch, Kerry L Tucker, Sandra Blaes. Definition of a critical spatiotemporal window within which primary cilia control midbrain dopaminergic neurogenesis. Neurogenesis (Austin, Tex.). vol 3. issue 1. 2020-10-01. PMID:28090543. |
midbrain dopaminergic (mda) neurons are generated in the ventral midbrain floor plate depending on sonic hedgehog (shh) signaling for induction. |
2020-10-01 |
2023-08-13 |
Not clear |
| Simone Mesman, Johannes A van Hooft, Marten P Smid. Frontiers in molecular neuroscience. vol 9. 2020-10-01. PMID:28133444. |
mesodiencephalic dopaminergic (mdda) neurons originate at the floor plate and floor plate-basal plate boundary of the midbrain ventricular zone. |
2020-10-01 |
2023-08-13 |
Not clear |
| Laura Hühner, Jennifer Rilka, Ralf Gilsbach, Xiaolai Zhou, Venissa Machado, Björn Spitta. Interleukin-4 Protects Dopaminergic Neurons Frontiers in molecular neuroscience. vol 10. 2020-10-01. PMID:28337124. |
parkinson's disease (pd) is one the most common neurodegenerative disease and is characterized by the progressive loss of midbrain dopaminergic (mda) neurons in the substantia nigra resulting in bradykinesia, tremor, and rigidity. |
2020-10-01 |
2023-08-13 |
Not clear |
| Wei Liu, Qishun Zhang, Jianlei Zhang, Wujun Pan, Jingya Zhao, Yuming X. Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease. Cell & bioscience. vol 7. 2020-10-01. PMID:28439401. |
parkinson disease (pd) is the most common movement disturbance characterized by the loss of dopaminergic (da) neurons in midbrain. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yunseon Jang, Min Joung Lee, Jeongsu Han, Soo Jeong Kim, Ilhwan Ryu, Xianshu Ju, Min Jeong Ryu, Woosuk Chung, Eungseok Oh, Gi Ryang Kweon, Jun Young He. A High-fat Diet Induces a Loss of Midbrain Dopaminergic Neuronal Function That Underlies Motor Abnormalities. Experimental neurobiology. vol 26. issue 2. 2020-10-01. PMID:28442947. |
a high-fat diet induces a loss of midbrain dopaminergic neuronal function that underlies motor abnormalities. |
2020-10-01 |
2023-08-13 |
mouse |
| Yogy Simanjuntak, Jian-Jong Liang, Yi-Ling Lee, Yi-Ling Li. Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells. Frontiers in microbiology. vol 8. 2020-10-01. PMID:28443089. |
jev highly targets dopaminergic neuron-rich brain regions including the thalamus and midbrain. |
2020-10-01 |
2023-08-13 |
human |
| Denis Pavăl, Florina Rad, Răzvan Rusu, Alexandru-Ştefan Niculae, Horaţiu Alexandru Colosi, Iuliana Dobrescu, Eleonora Dronc. Low Retinal Dehydrogenase 1 (RALDH1) Level in Prepubertal Boys with Autism Spectrum Disorder: A Possible Link to Dopamine Dysfunction? Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 15. issue 3. 2020-10-01. PMID:28783931. |
raldh1 has key functions in the midbrain dopaminergic system, which influences motivation, cognition, and social behavior. |
2020-10-01 |
2023-08-13 |
Not clear |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease. Neural regeneration research. vol 12. issue 11. 2020-10-01. PMID:29239326. |
targeting transcriptional regulators to regenerate midbrain dopaminergic axons in parkinson's disease. |
2020-10-01 |
2023-08-13 |
Not clear |
| Arianna Colini Baldeschi, Eugenia Pittaluga, Federica Andreola, Simona Rossi, Mauro Cozzolino, Giuseppe Nicotera, Gianluca Sferrazza, Pasquale Pierimarchi, Annalucia Serafin. Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in Frontiers in aging neuroscience. vol 10. 2020-10-01. PMID:29449807. |
atrial natriuretic peptide acts as a neuroprotective agent in in the last decades increasing evidence indicated a crucial role of the wnt/β-catenin signaling in development of midbrain dopaminergic (mda) neurons. |
2020-10-01 |
2023-08-13 |
Not clear |
| Anna-Elisa Roser, Lucas Caldi Gomes, Rashi Halder, Gaurav Jain, Fabian Maass, Lars Tönges, Lars Tatenhorst, Mathias Bähr, André Fischer, Paul Lingo. miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons. Molecular therapy. Nucleic acids. vol 11. 2020-10-01. PMID:29858093. |
mir-182-5p and mir-183-5p act as gdnf mimics in dopaminergic midbrain neurons. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yaqi Ding, Chenqi Xin, Cheng-Wu Zhang, Kah-Leong Lim, Hang Zhang, ZhenQian Fu, Lin Li, Wei Huan. Natural Molecules From Chinese Herbs Protecting Against Parkinson's Disease via Anti-oxidative Stress. Frontiers in aging neuroscience. vol 10. 2020-10-01. PMID:30233351. |
the major pathological features of pd include loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snpc) of the midbrain and the presence of α-synuclein-enriched lewy bodies. |
2020-10-01 |
2023-08-13 |
Not clear |
| Anja Pišlar, Larisa Tratnjek, Gordana Glavan, Marko Živin, Janko Ko. Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease. Frontiers in molecular neuroscience. vol 11. 2020-10-01. PMID:30450037. |
parkinson's disease (pd) is a neurodegenerative disorder characterized by loss of midbrain dopaminergic neurons in the substantia nigra pars compacta (snc). |
2020-10-01 |
2023-08-13 |
Not clear |
| Zachary Freyberg, Ryan W Loga. The Intertwined Roles of Circadian Rhythms and Neuronal Metabolism Fueling Drug Reward and Addiction. Current opinion in physiology. vol 5. 2020-10-01. PMID:30631826. |
midbrain dopaminergic neurons projecting from the ventral tegmental area to the nucleus accumbens play crucial roles in substance-induced neural and behavioral plasticity. |
2020-10-01 |
2023-08-13 |
Not clear |
| Dejie Chen, Fenfei Gao, Xiaokuang Ma, Jason Brek Eaton, Yuanbing Huang, Ming Gao, Yongchang Chang, Zegang Ma, Taleen Der-Ghazarian, Janet Neisewander, Paul Whiteaker, Jie Wu, Quanxi S. Cocaine Directly Inhibits α6-Containing Nicotinic Acetylcholine Receptors in Human SH-EP1 Cells and Mouse VTA DA Neurons. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:30837868. |
alpha6-containing nicotinic acetylcholine receptors are primarily found in neurons of the midbrain dopaminergic (da) system, suggesting these receptors are potentially involved in drug reward and dependence. |
2020-10-01 |
2023-08-13 |
mouse |
| Soledad Marton, Bruno González, Sebastián Rodríguez-Bottero, Ernesto Miquel, Laura Martínez-Palma, Mariana Pazos, José Pedro Prieto, Paola Rodríguez, Dalibor Sames, Gustavo Seoane, Cecilia Scorza, Patricia Cassina, Ignacio Carrer. Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:30890941. |
although previous reports have shown ibogaine's ability to induce gdnf expression in rat midbrain, there are no studies addressing its effect on the expression of gdnf and other neurotrophic factors (nfs) such as brain derived neurotrophic factor (bdnf) or nerve growth factor (ngf) in distinct brain regions containing dopaminergic neurons. |
2020-10-01 |
2023-08-13 |
human |